What does Ginkgo Bioworks do?

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum.

Is Ginkgo Bioworks (DNA) stock worth a bet?

Ginkgo Bioworks ( DNA) stock has fallen out of favor in the market. However, Cathie Wood appears to remain very bullish on the company, buying more DNA stock yesterday. The debate as to whether this growth stock is currently worth a bet rages on. This week has proven to be a rough one for investors in Ginkgo Bioworks (NYSE: DNA) stock.

Is Ginkgo Bioworks Holdings NYSE or NYSE?

Ginkgo Bioworks Holdings, Inc. is currently listed on NYSE under DNA. One share of DNA stock can currently be purchased for approximately $0.56. Is Ginkgo Bioworks Holdings, Inc. listed on the NASDAQ or NYSE? Ginkgo Bioworks Holdings, Inc. is listed on the NYSE as (NYSE:DNA). What is Ginkgo Bioworks Holdings, Inc.'s stock symbol?